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Introduction
Increased intraocular pressure (IOP) is a major risk factor
for developing ocular disease such as primary open-angle
glaucoma. Plasminogen activator inhibitor 1 (PAI-1) plays
a role in the turnover and degradation of extracellular
matrix proteins (ECM) which are thought to play a role in
the pathogenesis of increased IOP. To determine if an
independent association exists between serum PAI-1 and
IOP in humans.
Methods
A cross-sectional study with participants from the
Guangzhou biobank cohort study (GBCS-CVS) aged
50–85 years were recruited and received a medical check-
up including measurement of serum PAI-1, IOP, blood
pressure, fasting LDL- and HDL-cholesterol, glucose and
obesity measures. Information on socioeconomic and life-
style factors was also collected. Subjects were divided into
tertiles based on serum PAI-1 and a logistic regression
analysis was performed to derive an odds ratio for having
high IOP for each tertile. Personal, social and vascular
confounders were adjusted for.
Results
The risk of increased IOP was significantly raised with
higher serum PAI-1, with adjusted odds ratios (95% con-
fidence intervals) for second and third tertiles of 1.31
(0.81-2.12) and 1.81 (1.15-2.83), respectively. Haemato-
crit, glycosylated haemoglobin (HbA1c), heart rate, and
high-density lipoprotein (HDL-C) were the only vascular
risk factors positively associated with serum PAI-1 levels
(p from 0.03 to <0.01).
Conclusions
There is a strong relationship between serum PAI-1 and
IOP in this older Chinese population. Further studies
are needed to confirm these findings in this and other
populations.
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